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Abstract 
 
 
MICROBIAL EVALUATION OF THE CALAMUS™ HEATED GUTTA-
PERCHA DELIVERY SYSTEM  
 
By Christopher J. Smart, DDS 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
in Dentistry at Virginia Commonwealth University.  
 
Virginia Commonwealth University, 2013. 
 
Director: Karan J. Replogle, DDS, MS 
Program Director, Department of Endodontics 
 
 
 
If gutta-percha cartridges are contaminated with bacteria prior to obturation then contamination 
of the root canal system may result. Successful treatment not only depends on bacterial 
elimination but also depends on prevention of recontamination.  This study was motivated by the 
observation that endodontists frequently use single use gutta-percha cartridges on multiple 
patients.  The goal of this study was to determine if cross contamination occurred when a single 
gutta-percha cartridge in the Calamus™ Flow System was used on multiple patients.  An 
effective recovery method was established during a pilot study using Enterococcus faecalis as a 
sample bacterium.  Microbial recovery was obtained using standard media.  The Calamus™ 
heated gutta-percha delivery system was evaluated to determine the percentage of cartridges with 
recoverable microorganism under four conditions.  Results showed that for cartridges tested 
immediately after removal from manufacturer’s packaging, the observed negative outcome was 
0/10 (0%).  For cartridges used on a single patient with an alcohol wipe after use, the negative 
 outcome was 0/20 (0%).  For cartridges used on a single patient with no alcohol wipe after use, 
the negative outcome was 1/20 (5%).  For cartridges used on three patients with an alcohol wipe 
after each use, the number of observed negative outcomes was 0/20 (0%).  Using 95% score 
confidence intervals, the results indicate that the percentage of cartridges with recoverable 
microorganism under the four conditions is below 27.8% for cartridges sampled from 
manufacturer’s packaging, 16.1% for cartridges used on a single patient with a alcohol wipe after 
use, 23.6% for cartridges used on a single patient with no alcohol wipe after use, and 16.1% for 
cartridges used on three patients with an alcohol wipe after each use.  Evidence from this study 
indicates using Calamus™ flow cartridges on multiple patients vs. single patient does not lead to 
an increased contamination risk. 
 
 
 
 
 
 
 
 
 
 
 
  
 
Introduction 
 
 
 
The goal of root canal treatment is to eradicate microbiota infecting the root canal system 
creating a sterile environment and to obturate with a 3-D obturation that seals the canal from 
reinfection.  Due to the complex anatomy of the root canal system this is difficult with current 
instruments and techniques.  Bacterial elimination is accomplished by mechanical 
instrumentation techniques using hand and rotary files in combination with various chemical 
irrigants, interappointment medicaments, and obturation materials.  Maintaining the chain of 
asepsis is extremely important to prevent bacterial contamination of the root canal system.  
Based on current infection control concepts, the instruments and materials used during 
endodontic treatment (including gutta-percha delivery systems) must be as bacteria-free as 
possible. 
Role of Bacteria 
Since the first discovery of oral bacteria or “animalcules” in the late 1600’s, dentistry has 
made extensive progress in treating dental diseases (1).  Miller (1894) discovered that bacteria 
could infect and persist in the pulpal tissues causing pulpal disease (2).  This study helped 
change the way dentists looked at bacterial involvement with pulpal symptoms and pulpal 
disease in patients.   
Kakehashi, et al. conducted a landmark study using an animal model involving one group 
of germ-free rats in which pulpal exposure was induced and a second group of standard germ-
present rats in which pulpal exposure was induced.  The germ-free rats with orally exposed 
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pulpal tissue and periapical tissues showed no signs of apical periodontitis, while standard rats 
showed signs of pulpal necrosis and apical periodontitis (3).   
In a subsequent study, Sundqvist, showed that traumatized incisors with clinically intact 
crowns and necrotic pulp remained normal and that only the teeth that harbored bacteria 
developed apical periodontitis (4).  Moller et al. showed that aseptically devitalized sealed teeth 
remained disease-free after a period of 6-7 months.  However, teeth that were infected by oral 
flora developed apical periodontitis (5).  These three studies by Kakehashi, Sundqvist, and 
Moller were the foundation of and furthered understanding of the bacterial etiology of periapical 
disease.  
Later studies showed the effect of bacteria on the outcome of endodontic treatment.  In a 
clinical study of 55 root canals, Sjogren et al. demonstrated that having a bacteria-free canal 
before obturation positively affected the success of endodontic treatment.  Ninety four percent of 
cases that yielded a negative culture were healed at five years’ recall.  However, in cases that 
yielded positive samples prior to obturation, the success rate of treatment was only 68%.  This 
study emphasized the importance of sterilization of the root canal for optimal outcome (6).   
Microbiology of Endodontics 
 
When the pulp succumbs to necrosis, bacteria begin to colonize it immediately. 
Facultative anaerobes dominate the initial stages of necrosis, but as necrosis progresses, obligate 
anaerobes take over (7).  Major factors affecting bacteria in the necrotic pulp include oxygen 
tension, type and availability of nutrients, as well as bacterial interactions.  Low oxygen tension 
is a result of the bacteria consuming the oxygen and the loss of blood supply to the pulp (8-10). 
Saccharolytic bacterial species dominate initially.  These species metabolize products of 
the pulp, proteins and other components of saliva and metabolic byproducts of other bacteria. As 
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the infection matures, asaccharolytic bacterial species dominate as the infection progresses 
metabolizing proteins into amino acids (11). 
The specific bacteria most commonly isolated from primary endodontic infections 
include Fusobacterium, Streptococcus, Porphyromonas, Prevotella, Eubacterium, 
Peptostreptoccus, Propionibacterium and Campylobacter species (12).  Classic studies have 
shown that black pigmented rods are more likely to be associated with clinical symptoms such as 
pain and swelling (13, 14).   
Bacteria harboring in root canals can either be in a planktonic form, biofilm form, or both 
(15).  Planktonic microbiota have been shown to be easily eradicated by different methods, 
whereas biofilm microbiota have been shown to be resistant.  Biofilms are communities of 
organisms attached to root canal walls that consist of an extracellular polysaccharide matrix 
which helps protect bacteria from the harsh environment, allows for metabolic commensalism 
among different species, and aids resistance to antimicrobial agents (16-19). 
Completely removing bacterial biofilms from the root canal system is difficult and could 
be one reason why apical periodontitis appears in secondary infections.  Bacteria that are often 
associated with treatment failures are different from the bacteria in primary infections.  
Secondary infections contain fewer bacteria species and are dominated by gram-positive 
facultative anaerobes including Streptococci, Lactobacilli, Propionibacterium species, yeasts, 
Enterococcus faecalis and Actinomyces species (20-23).  E. faecalis is one of the most frequently 
isolated bacteria from failing previously treated teeth. 
Enterococcus faecalis 
E. faecalis is a gram-positive facultative anaerobic coccus which is a normal inhabitant of 
human intestinal flora.  It can cause life-threatening infections in humans, especially in the 
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nosocomial environment, where the naturally high levels of antibiotic resistance found in E. 
faecalis contributes to its pathogenicity (24). 
Clinical studies have shown that E.faecalis has been isolated from oral cavity and 
gingival sulcus and can be present in untreated root canals with primary infections (25-28).  
However, it has been most commonly isolated from root canal-treated teeth with apical 
periodontitis.  Several studies revealed that E. faecalis is the most frequent species isolated with 
prevalence values reaching up to 90% of cases in teeth with apical periodontitis (19, 20, 24, 27).  
It has also been estimated that root canal-treated teeth are nine times more likely to harbor E. 
faecalis than primary infections (19).  It is a fastidious organism that is thought to invade root 
canals during treatment from the oral fluids and then persists due to its ability to adapt to 
ecological conditions and survive (30).   
E. faecalis has been shown to be resistant to high pH calcium hydroxide (31, 32).  This 
resistance seems to be related to its internal functional proton pump that acidifies the cell 
cytoplasm (33).  The ability of E. faecalis to penetrate deep into dentinal tubules to escape from 
chemomechanical preparation and intracanal medicaments is another survival mechanism (34).  
E. faecalis is capable of entering a viable but non-cultivable (VBNC) state.  This survival 
mechanism is utilized by other bacteria as well as E. faecalis when exposed to environmental 
stress (35, 36).  In the VBNC state, bacteria are able to survive periods of starvation and then 
resume their growth when nutrients become available again (30).  E. faecalis has been shown to 
survive starvation in root canal-treated teeth providing a nidus for subsequent infection (37).  
E. faecalis has also demonstrated that it can form coaggregates with other bacterial species 
resulting in biofilms (38).  The presence of E. faecalis in the root canal system, its fastidious 
survival mechanisms, and its association with secondary infections make it essential that the 
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antimicrobial measures taken before obturation be as effective as possible against this 
microorganism. 
Gutta-Percha 
The success of treatment not only depends on bacterial elimination but also depends on 
the prevention of recontamination after cleaning and shaping the root canal system.  Therefore, 
obturation should not introduce additional irritants into the root canal system that could 
ultimately decrease successful treatment outcomes.   
 Material used for obturation of root canals has changed as the field of endodontics has 
evolved.  Obturating materials have included both pastes and solid materials such as silver cones.  
Gutta-percha, carrier-based gutta-percha, and Resilon are the materials that are primarily used 
today, with gutta-percha being the most commonly used obturation material.   
Gutta-percha fulfills most of the ideal characteristics originally outlined by Grossman 
(1940).  The ideal characteristics of an obturating material are: 1)  easily introduced into the root 
canal, 2)  seals the canal laterally as well as apically, 3)  does not shrink after being inserted, 4)  
is impervious to moisture, 5)  is bacteriostatic or at least does not encourage bacterial growth, 6)  
is radiopaque, 7)  does not stain tooth structure, 8) does not irritate periradicular tissues, 9)  is 
sterile, or easily and quickly sterilized, immediately before the insertion, and 10)  is removed 
easily from the root canal, if necessary (39). 
Gutta-percha (Palaquium) is a genus of tropical trees native to Southeast Asia and 
northern Australasia.  The milky exudate from the trees is evaporated and the resulting material 
is called gutta-percha.  Chemically, gutta-percha is a polyterpene, a polymer of isoprene, or 
polyisoprene, specifically the trans-1,4-polyisoprene (40).  It is the dominant isomer in both 
gutta-percha and balata.   
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Gutta-percha was introduced as a root canal filling material in 1847 by Hill who 
developed the material and called it “Hill’s-stopping”.  It was composed of a mixture of bleached 
gutta-percha and carbonate of lime and quartz (40).  Bowman (1867) was the first to use gutta-
percha for a root canal filling on an extracted molar (40).  Later Perry (1883) used pointed gold 
wire wrapped with soft gutta-percha which he rolled and packed into the canal (40).  
The first commercial manufacture of gutta-percha points was by S.S White Company in 
1887 (40).  A newer mixture of gutta-percha was introduced by Rollins in 1893.  He added pure 
oxide of mercury to the gutta-percha.  This product was removed later due to dangerous levels of 
mercury (40).  In 1914 Callahan introduced softening and dissolution of gutta-percha with the 
use of rosins in obturation (40).  In 1959 Ingle and Levine were the first to propose 
standardization of root canal instruments and filling materials.  Standardized gutta-percha was 
introduced to the profession in 1959 (41). 
Gutta-percha exists in two crystalline forms α and β.  The mechanical properties of the α 
and β forms are the same except when heated.  Heating gutta-percha results in volumetric 
difference (42, 43, 44). When in β form, gutta-percha is compactable.  When heated, it changes 
to α phase and becomes pliable and therefore, can be made to flow.  When α phase gutta-percha 
cools normally, it crystallizes to the β form with a slight shrinkage of between 1 and 2% (45).   
Gutta-percha has both advantages and disadvantages.  Shrinkage is one disadvantage.  
Another is its inability to bond to dentin.  The major advantages of gutta-percha are its plasticity, 
ease of manipulation, minimal toxicity, radiopacity, and ease of removal with heat or solvents 
(44).  Gutta-percha cones consist of approximately 20% gutta-percha, 65% zinc oxide, 10% 
radiopacifiers, and 5% plasticizers (46).  These chemical additives alter the material behavior 
compared to pure gutta-percha (47).   
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Obturation Methods 
There is very little scientific evidence to support one method of obturation versus another 
in terms of outcomes of success or failure.  Lateral compaction, warm vertical compaction, 
continuous wave compaction, warm lateral compaction and carrier based compaction are the 
methods available. 
Currently there are multiple thermoplasticized injectable gutta-percha obturating systems 
used today.  The concept of obturating root canals using thermoplasticized injectible gutta-
percha was introduced by Ye et al (48).  Thermoplascticized injectible gutta-percha may be used 
as a primary technique or, as it is used most often today, as a back-filling technique to obturate 
the remaining canal space after initial compaction technique.  
 Thermoplasticized injectable gutta-percha obturating systems include pellet based units 
and cartridge based units.  The Obtura (Obtura Spartan, Earth City, MO) and HotShot (Discus 
Dental, Culver City, CA) use gutta-percha pellets.  These units require gutta-percha pellets to be 
inserted into the delivery system gun, and then the gutta-percha pellet is heated to 150
o
 to 200
o
C 
prior to injection into the canal.  The Calamus (DENTSPLY Tulsa Dental Specialties, Tulsa, 
OK), Elements (SybronEndo, Orange, CA), and Ultrafill 3D (Coltene/Whaledent, Cuyahoga 
Falls, OH) use gutta-percha cartridges which are inserted into the system.  The Ultrafill™ system 
is a low heat system that heats preloaded gutta-percha cartridges from 70
o
 to 90
o
C prior to 
injection into the canal.  The Elements™ and Calamus™ systems heat preloaded gutta-percha 
cartridges from 60
o
 to 200
o
C prior to injection into the canal.  These systems have been 
developed with minimal guidelines for clinical asepsis.  The only scientific evidence available 
for these units comes from studies completed on the Obtura™ and the Ultrafill™ systems (49, 
50).  The focus of the present study is based on the Calamus™ system. 
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The Calamus™ unit cartridges come in manufacturing packages that give no information 
on how the product is prepared.  The Calamus™ directions outline the use for cartridges and are 
as follows: 
1. Cartridges are for single patient use. 
2. Prior to using a cartridge on a patient, wipe the cartridge tip with alcohol or a 
disinfectant. 
3. Store cartridges at room temperature. 
4. Do not immerse the cartridges into any liquid. 
5. Do not use cartridges after the expiration date. 
6. Cartridges CANNOT be re-heated and/or re-used. 
Clinicians can assume that if the gutta-percha pellets or cartridges are contaminated with 
bacteria prior to obturation the contamination of the root canal system may result.  Furthermore, 
some clinicians may use these pellets and single use cartridges on multiple patients resulting in 
cross-contamination.  The success of treatment not only depends on bacterial elimination but also 
depends on the prevention of recontamination after cleaning and shaping the root canal system.  
Therefore, obturation should not introduce additional irritants into the root canal system that 
could ultimately decrease successful treatment outcomes.   
This study was motivated by the observation that endodontists frequently use single use 
gutta-percha cartridges on multiple patients.  The goal of this study was to determine if cross 
contamination occurred when a single gutta-percha cartridge in the Calamus™ Flow System was 
used on multiple patients. 
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Materials and Methods 
 
 
 
All non-surgical root canal treatment (NSRCT) (vital and necrotic) or non-surgical 
retreatment cases treated in the VCU School of Dentistry Graduate Endodontic Practice are 
obturated using warm continuous wave obturation which utilizes thermoplasticized gutta-percha 
cartridges or pellets.  Each cartridge contains enough gutta-percha to obturate 2-4 cases. These 
cartridges are discarded after use.  All cases are treated using a standard protocol for cleaning 
and shaping, irrigation and obturation.  This study included cases treated during Spring Semester 
2012.  
The gutta-percha cartridges used on patients that presented for NSRCT at VCU School of 
Dentistry were evaluated after continuous wave obturation for the existence of microorganisms 
under four conditions: 
1. 10 cartridges immediately removed from manufacturer’s packaging, 
2. 20 cartridges  used on single patients cleaned with an alcohol wipe after use, 
3. 20 cartridges used on single patients with no alcohol wipe after use, 
4. 20 cartridges (1 cartridge used per 3 patients) with an alcohol wipe after each use. 
 All materials and methods were under the control of one operator.  The media used for 
recovery of microorganisms was sterile saline and the media used for growth of microorganisms 
included brain-heart infusion broth (BHIB) and brain-heart infusion agar (BHI agar) plates. 
BHIB and BHI agar are highly nutritious general-purpose growth media used for culturing 
fastidious and nonfastidious microorganisms.  One Calamus™ Dual unit was used throughout 
the study (Fig. 1).  Calamus™ cartridges from only unopened manufacturer’s storage packages 
- 10 - 
 
were used in this study.  The Calamus™ gutta-percha cartridge is an aluminum prefilled capsule 
that contains gutta-percha with a silver cartridge tip (Fig. 2).   
Pilot Study Sample Preparation 
The pilot study sample preparation is shown in Figure 3.  Cartridges used to evaluate the 
recovery method used were inoculated with an overnight culture of E. faecalis.  An overnight 
stock culture of E.faecalis was prepared by thawing the culture in the biological safety cabinet 
and pipetting a10 ul aliquot of E.faecalis into 5 ml of BHI broth.  The culture was incubated at 
37
o
C for 24hrs.  The cartridges were prepared by removing them from packaging with sterile 
forceps and gloves, wiped with a 2x2 alcohol wipe, allowed to dry in the biological safety 
cabinet, and pre-weighed on a sterile laboratory scale.  Next, all tips were inoculated by the same 
protocol by inserting the tip of the cartridge to the hub in the overnight culture with sterile 
forceps and holding it there for 10 seconds.  Tips were then removed in the biological safety 
cabinet, dried, and reweighed. 
After drying, tips were treated in three ways.  One tip was placed into a tube containing 3 
ml of sterile saline with forceps and allowed to incubate at room temperature for 24hrs.  The 
second tip was placed into another tube containing 3ml of sterile saline with forceps and was 
vortexed in preparation for immediate recovery.  The third tip was held with sterile forceps and 
swabbed with a sterile cotton swab soaked in sterile saline.  The swab was then inserted and 
twirled into a tube containing 3ml of sterile saline.  This 3 ml volume was sufficient to cover the 
entire silver cartridge tip but only partially cover the aluminum cartridge of the gutta-percha.  
Tubes were labeled according to how the sample was treated.   
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Figure 3. Pilot Study Sample Preparation and Recovery Method 
Preparation of Manufacturer’s and Patient Samples 
The preparation of manufacturer’s and patient samples is given in Figure 4.  In all patient 
cases in this study, hand and rotary instrumentation in combination with antimicrobial solutions 
of 5.25% sodium hypochlorite (NaOCl) and 17% etheylenediamine tetraacetic Acid (EDTA) 
were used prior to obturation.  If a case was non-vital, 2% chlorhexidine (CHX) was added as an 
antimicrobial irrigant.  If the case was a non-surgical retreatment the addition of chloroform was 
used prior to obturation.  In multiple visit cases calcium hydroxide (Ca (OH)2) was used as an 
intracanal intraappointment medicament prior to obturation. 
Preparation of new samples prior to use followed manufacturer’s instructions and utilized 
the following protocol.  Cartridges were removed with sterile forceps and gloves, wiped with a 
2x2 alcohol wipe, and placed into the flow hand piece prior to patient usage.  After cleaning and 
shaping procedures were completed, master cones were fitted and down packed with the pack 
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hand piece.  When down packing was completed the Calamus™ flow hand piece with the 
inserted cartridge was used to backfill the canals.  After the last usage of the flow hand piece the 
cartridge tip was treated in two ways, it was wiped with a 2x2 alcohol wipe or was not wiped.  
After the patient was dismissed from the operatory, the cartridge was removed from the flow 
hand piece with sterile gloves and forceps and placed into a test tube containing 3 ml of sterile 
saline and labeled according to how it was treated (alcohol wipe or no alcohol wipe). 
Preparation of the samples for multiple cases on patients followed single patient 
procedures with minor differences.  After each case was obturated and before its next use, the 
cartridge tip was wiped with a 2x2 alcohol wipe.  After the final usage the cartridge tip was 
placed aseptically into a 3ml of sterile saline. 
 
Figure 4. Patient and Manufacturer’s Sample Preparation 
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Pilot Study Recovery Method 
The recovery method used in the pilot study is shown in Figure 3.  A standard Drop 
Plating method on BHI plates was used to evaluate the number of bacteria from the overnight 
cultures and the number of bacteria recovered from Calamus™ cartridge tip samples.   
Overnight culture determination was done according to the following protocol. A 10 ul 
aliquot of overnight culture was pipetted into a centrifuge tube containing 990ul of BHI broth 
labeled tube L and vortexed.  From tube L, a 100 ul aliquot was pipetted into another tube 
containing 900 ul of BHI broth labeled M and vortexed.  From tube M, a 250 ul aliquot was 
pipetted into another tube containing 750 ul of BHI broth labeled N and vortexed.  Dilutions 
were carried out in tubes labeled O, P, Q, and R using the same method as from tube M to tube 
O.  Twenty ul aliquots from tubes M through R were drop plated in triplicate onto BHI plates.  
All plating was done in duplicate.  The two Calumus™ tip samples and the sterile cotton swab 
sample followed the same protocol but differed in the fact that one of the Calamus™ tip sample 
was treated 24hrs later to mirror patient treatment.  A 20 ul aliquot was taken directly from the 
sample drop plated on the BHI plate.  A 250 ul aliquot was pipetted into a centrifuge tube 
containing 750 ul of BHI broth labeled B and vortexed.  From tube B, a 250 ul aliquot was 
pipetted into another tube containing 750 ul of BHI broth labeled C and vortexed.  Dilutions 
were carried out in tubes labeled D, E, and F using the same method as from tube B to tube C.  
The 20 ul aliquots from tubes B through C were drop plated into triplicate onto BHI plates (Fig. 
4).  All plating was done in duplicate. 
Patient and Manufacturer’s Samples Recovery Method  
The patient and manufacturer’s samples recovery method is shown in Figure 4.  All test 
tube samples from patient usage and manufacturer’s packaging were labeled accordingly.  The 
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samples remained at room temperature for 24-48hrs. After 24-48hrs samples were taken to a 
microbiology lab for sampling in a biological safety cabinet.  The following protocol was 
utilized for all samples after remaining at room temperature for 24-48hrs: 
1.  Samples containing the cartridges were vortexed for 30 seconds to free any adhering 
microorganisms from exposed surfaces.  
2.  Two 250 ul aliquots from the sample were directly plated and streaked onto two 
separate BHI agar plates labeled anaerobic culturing.  
3. Two 250 ul aliquots from the sample were directly plated and streaked onto two 
separate BHI agar plates labeled aerobic culturing.  
4. Two 250 ul aliquots from the sample were pipetted into two test tubes containing 9.0 
ml of BHIB labeled anaerobic culturing and were vortexed. 
5. Two 250 ul aliquots from the sample were pipetted into two test tubes containing 9.0 
ml of BHIB labeled aerobic culturing and were vortexed. 
6. The BHI agar plates and BHIB test tubes were placed in two separate jars labeled 
aerobic or anaerobic of the Anoxomat system.  The Anoxomat system is a system for 
culturing anaerobes and micro-aerobes in any laboratory, clinical or industrial setting.  
It is a complete and unique system creating rapidly and automatically anaerobic, 
micro-aerophilic or capnophilic conditions in an anaerobic jar.  The anaerobic jar 
conditions included 80% N2, 10% CO2, 10% H2, and 0 % O2.  The aerobic jar 
conditions included 80% N2, 10% CO2, 10% H2, and 6 % O2.   
7. When the jars completed their cycles to create this environment they were then 
incubated at 37
o
C for 24-48 hrs. 
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8. After 24-48hrs BHI agar plates and BHIB test tubes were visually evaluated for the 
presence of microorganisms.  If colonies were not visualized on the BHI agar plates 
or the BHIB test tube was not turbid then the samples were considered negative.  If 
colonies were visualized on the BHI agar plates or the BHIB test tube appeared turbid 
then the samples were considered positive. 
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Results 
 
 
An effective recovery method for E. faecalis inoculated gutta-percha cartridges was 
established during a pilot study.  This method effectively recovered inoculated bacteria from the 
cartridge tips allowing the use of this method on patient samples.  Figure 5 shows that tips 
sampled after 24 hours resulted in the highest recovery of bacteria at 4.97% followed by tips 
tested immediately at 4.52%. The cotton swabs recovered the lowest amount of bacteria at 
3.19%. 
 
Figure 5. Pilot Study Percent Recovery Graph  
Following the pilot recovery studies, gutta-percha cartridges used in the Calamus™ Flow 
Gutta-Percha Delivery System were evaluated to determine if cross contamination occurred 
when a single use gutta-percha cartridge was used on multiple patients.  Gutta-percha cartridges 
observed negative outcomes were determined under four conditions: 
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1. 10 cartridges immediately removed from manufactures packaging, 
2. 20 cartridges used on single patients cleaned with an alcohol wipe after use, 
3. 20 cartridges used on single patients with no alcohol wipe after use, 
4. 20 cartridges (1 cartridge used per 3 patients) with an alcohol wipe after each use. 
The observed negative outcome was 0/10 (0%) for cartridges tested immediately after 
removal from manufacturer’s packaging.  The observed negative outcome for cartridges used on 
a single patient cleaned with an alcohol wipe after use was 0/20 (0%).  The observed negative 
outcome for cartridges used on a single patient with no alcohol wipe after use was 1/20 (5%).  
The observed negative outcome for cartridges used on three patients (60 patients) with an alcohol 
wipe after each use was 0/20 (0%). 
Using 95% score confidence intervals, results from Figure 6 indicates that the percentage of 
cartridges with recoverable microorganism under the four conditions is below 27.8% for 
cartridges taken directly out of manufacturer’s packaging, 16.1% for cartridges used on a single 
patient cleaned with an alcohol wipe, 23.6% for cartridges used on a single patient with no 
alcohol wipe, and 16.1% for cartridges used on three patients with an alcohol wipe after each 
use. 
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 Figure 6: 95% Confidence Intervals of Observed Negative Cartridges 
 
 
 
 
Discussion 
 
 
 
As stated earlier, Calamus™ gutta-percha cartridges are marketed as single use to prevent 
cross contamination between patients. This study was motivated by the observation that 
endodontists frequently use these single use gutta-percha cartridges on multiple patients.  The 
purpose of this study was to determine if cross contamination occurred when a single gutta-
percha cartridge in the Calamus™ Flow System was used on multiple patients. 
Microbial recovery from cartridges among patient samples in this study was all negative for 
99 out of 100 patients (60 total cartridges).  The high number of negative cultures may be due to 
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the effects of mechanical instrumentation techniques in combination with various chemical 
irrigants and interappointment medicaments prior to obturation.  Furthermore, the temperature 
(170
o
C) of the obturation unit may have been lethal to remaining bacteria on or in the cartridge 
tip prior to use (49).  
Prior to this study there has only been one study that completed microbiological 
evaluation of high heat gutta-percha delivery systems.  Winford et al. tested the Unitek Obtura™ 
heated gutta-percha system to determine whether microorganisms have the ability to survive 
passage through the mechanism or to survive on the applicator tip of the instrument during 
clinical use.  No organisms tested survived the passage through the heated chamber or were 
demonstrable on the applicator tip during clinical usage patterns.  The authors suggest that the 
use of NaOCl, the temperature of the applicator tip, and alcohol wiping the tip as being sufficient 
to control the microflora tested (50).  Their results are similar to the findings in this study.  The 
use of 5.25% NaOCl, 17% EDTA, 2% CHX, Ca (OH)2, multiple alcohol wipes, and the 170
o
C 
temperature of the Calamus™ unit may also have contributed to the lack of positive cultures.   
When looking at the results of this study it appears that a clinician may have a higher risk 
of obtaining a positive culture when using a new cartridge out of manufacturer’s packaging 
versus using a used one on multiple cases (27.8% for cartridges out of manufacturer’s packaging 
and 16.1% for cartridges used on multiple patients).  The results appear this way because only 10 
new cartridges were sampled resulting in a smaller sample size compared to the number of cases 
sampled (20).  One can assume if a higher sample size was used then the confidence intervals 
would have decreased thus making the risk of a positive culture equal to or below that of cases 
treated with alcohol wipes. 
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In conclusion, evidence from this study indicates using a single use Calamus™ cartridge 
on multiple patients versus one patient does not lead to an increased cross-contamination risk.  
Prior to adopting the use of single use patient cartridges on multiple cases as a standard of care 
the use of a single gutta-percha cartridge for multiple patients requires additional microbial 
studies to evaluate the Calamus™ flow gutta-percha cartridges under different clinical 
conditions.   
Study variables need to be controlled for case type, i.e. vital, non-vital, and retreatment.  
Sample size needs to be increased for all case types.  Increasing the sample size would have 
likely decreased the risk of obtaining positive cultures.  Statistical analysis across and among 
case type should be completed. 
The use of a single researcher added bias to the study.  Any future studies should attempt 
to remove this bias by adding more researchers. 
The use of a different culturable microorganism, the use of different growth media, and 
the utilization of more robust identification methods such as polymerase chain reaction methods 
might more reliably allow for prediction of cross-contamination. 
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Appendix 
 
 
 
Figure 1. Calamus Unit 
 
 
 
 
Figure 2. Cartridge 
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Table 1. Percent Recovery of Pilot Study 
 
Tips after 24hr Tips Immediately Cotton swabs immediately 
   0.026 0.026 0.0077 
0.059 0.081 0.009 
0.038 0.11 0.059 
0.059 0.085 0.11 
0.037 0.02 0.05 
0.14 0.02 0.02 
0.03 0.012 0.057 
0.059 0.15 0.03 
0.035 0.023 0.11 
0.085 0.11 0.013 
0.049799513 0.045234761 0.031925007 
   4.97% 4.52% 3.19% 
 
Table 2. Raw Data of Observed Negative Outcomes  
 
Raw Data Collection of Observed Negative Outcomes 
Singe use with alcohol 
wipe 
Single use with no 
alcohol wipe 
Multiple use with 
alcohol wipe 
Package Samples 
0 1 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0  
0 0 0  
0 0 0  
0 0 0  
0 0 0  
0 0 0  
0 0 0  
0 0 0  
0 0 0  
0 0 0  
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